Dunfermline-based Vets Now Ltd has been announced as the winner of the Scotland regional final of the £35 Million Bank of Scotland Corporate Entrepreneur Challenge. The company, based on Pitreavie Drive, is the UK's leading provider of out of hours emergency care for animals and has secured an incredible funding package of up to £5 million, free of interest and charges for three years, to turn their expansion plans into reality.Richard Dixon, Managing Director of Vets Now Ltd, said, "I am absolutely thrilled that we have won the Scottish regional final of the Entrepreneur Challenge. A lot of time and effort went into our presentation and we knew that the competition was going to be tough. I'm very proud of our team, without who Vets Now would not be what it is today."Winning the Challenge is going to have a fundamental impact on Vets Now, taking our business to a completely new level. The funding will allow us to make substantial growth and move the business into Europe. It will also increase the range of services we can provide to customers and increase the overall profile of our organisation."Richard will now go through to the national final in December, where he will compete against the winners from six other regions across the UK for the chance to be named ‘Entrepreneur of the Year' and the opportunity to benefit from four days mentoring from one of Britain's most successful and high profile entrepreneurs.Vets Now was chosen as the winner after Richard Dixon presented his business case and plans for the future to a panel of judges, including Willie Haughey from City Refrigeration and John Anderson from The Entrepreneurial Exchange. Willie, John and the rest of the judging panel then questioned Richard in their search for an entrepreneur who displayed flair, vision and creativity, coupled with solid business acumen and impressive plans for the future. The judging was followed by a dinner and award ceremony at Stirling Castle, at which the winner was announced.For more information visit http://www.theboschallenge.co.uk/
The European Advisory Board on Cat Diseases (ABCD) has issued new guidelines concerning rabies in cats.
The organisation, which is made up of 17 independent veterinary experts, meets 3 times a year to discuss major infectious feline diseases. The rabies guidelines are the latest in the series, which are available for download at: http://www.abcd-vets.org/guidelines/index.asp
If you had purchased £1000 of Northern Rock shares one year ago they would now be worth £4.95; with HBOS, earlier this week your £1000 would have been worth £16.50; £1000 invested in XL Leisure would now be worth less than £5; but if you bought £1000 worth of Tennents Lager one year ago, drank it all, then took the empty cans to an aluminium re-cycling plant, you would get £214.
So based on the above statistics the best current investment advice is to drink heavily and re-cycle.
According to the European Scientific Counsel for Companion Animal Parasites (ESCCAP), serious zoonotic diseases, currently rife across Europe, could be a far more serious threat to pet and human health in the UK than official figures suggest.
Vets and parasitologists at an ESCCAP meeting held in Bristol on 19th September, heard evidence that UK cases of diseases such as leishmaniosis and babesiosis are grossly under-reported. ESCCAP is urging vets and parasitologists to help raise awareness of the threat and lobby the Government to prevent further relaxation of pet movement restrictions.
According to DACTARI, the voluntary web-based Dog And Cat Travel And Risk Information scheme, just 19 cases of leishmaniosis, 10 babesiosis, 10 ehrlichiosis and one case of dirofilariosis had been recorded between 1 January 2003 and 30 September 2006, which are the latest figures reported on the Defra website.
But latest figures presented by Susan Shaw, senior lecturer in dermatological and applied immunology, revealed a screening programme underway at Bristol University casts serious doubts on the reliability of the Defra-backed service to monitor cases.
"From 2005 to 2007 we recorded 257 cases of leishmaniosis. The babesiosis cases you can multiply by about five, the ehrlichiosis cases by about 10 and dirofilariosis by three," Ms Shaw told delegates at the sixth ESCCAP meeting. "That is absolutely outrageous - we are dealing with a massive number of cases. I would be very concerned if we are making decisions for the UK based on the DACTARI figures."
Maggie Fisher, an independent consultant in veterinary parasitology and founding member of ESCCAP pointed out that the PETS (Pet Travel Scheme), has issued dogs and cats with passports for travel across Europe since 2000 and has proven immensely popular, with 76,000 dogs entering the UK in January to October 2007 alone.
"What is coming into the country with those animals is not well documented," said Mrs Fisher. Case studies point to harrowing experiences for individual families travelling with their dogs to mainland Europe unaware of the dangers. "One family thought they'd done everything they should because they followed the instructions under PETS. What they didn't realise is that they weren't protected against ticks, tick-borne diseases and worms whilst they were away and their dog picked up babesiosis."
Human health and veterinary professionals at the meeting explored the real threat and implications of parasites across Europe. Peter Deplazes of ESCCAP, Switzerland, reported that the human form of Echinococcus multilocularis claims three or four lives per year in Switzerland and is a very common endoparasitic diagnosis in dogs. Forty per cent of foxes are infected with E multilocularis.
Leishmaniosis causes renal failure in dogs, reported ESCCAP Spain's Lupe Miro Corrales, often leading to death or euthanasia. Worldwide more than 12 million people are already infected, and one in ten at risk of being infected. Stray dogs and cats are important carriers and almost 80 per cent of sero-positive dogs have no clinical signs.
Natural controls offered by the UK's island status are now under threat. Currently a derogation allows the UK, and four other EU member states, stricter controls to help maintain their Echinococcus multilocularis and tick-borne disease free status. It extends to July 2010 but comes up for review next year, pointed out Maggie Tomlinson from the Department of Health, who is taking the case to the EU Commission.
"I can say categorically that they are not keen for us to keep the derogation and it's going to be a very hard fight. We only have until January to push the Commission to make a decision."
Chairman-elect of ESCCAP Europe, James Duncan, pointed out the organisation is seeking to raise awareness of the serious risks posed by endo and ecto-parasites to human and animal health, and is developing independent guidelines and educational materials for their optimal control.
"There is no immediate panacea," he said. But those in the veterinary profession who are aware of the risks should take action. "It is up to you to lobby - put your voice to Government and influence the pet passport scheme. You can do that and it will help our cause because we are singing from the same hymn sheet."
Vetoquinol has announced the winners of the 2008 Marbocyl Achievement Awards. Six veterinary schools took part in the award scheme, which enabled them to recognise the achievements of either staff or students, with a prize fund of £2000 for each university.
Five of the vet schools have announced their 2008 winners, the University of Liverpool will announce its winners in January 2009. Those who have already received their awards this year are:
University of Bristol Dr Catherine Fuller, MRCVSMs Kathryn Murphy, MRCVSMichael Steele, MRCVSChristopher Hudson, MRCVSSamantha Taylor, MRCVS
All of the winners are members of staff nominated by their students for excellence in teaching.
University College DublinDr Carmel Mooney, MVB MPhil PhD DECVIM-CA MRCVS, for an outstanding performance as Clinical Director of the Veterinary Hospital at UCD.
University of CambridgeAdrian Wallace, BVSc (Hons), MACVSc (SAS), MRCVS for his clinical research paper , ‘A biomechanical comparison of six double-loop configurations for use in the lateral fabella suture technique for the cranial cruciate ligament deficient canine stifle', Journal of Veterinary and Comparative Orthopaedics and Traumatology, 2008. Catherine Stalin, MA, VetMB, MRCVS for her paper ‘Radiographic morphology of the cranial portion of the cervical vertebral column in Cavalier King Charles Spaniels and its relationship to syringomyelia', American Journal of Veterinary Research, 2008 Penny Watson, MA, VetMB, CertVR, DSAM, Dip ECVIM, MRCVS, European Specialist in Small Animal Medicine for her clinical research paper ‘Prevalence and breed distribution of chronic pancreatitis at post-mortem examination in first opinion dogs' Journal of Small Animal Practice, 2007.
University of GlasgowMark Lowrie, MA VetMB MRCVS, for his Clinical Research Abstract - "Acute phase proteins and immunoglobulin A in steroid responsive meningitis-arteritis"
Royal (Dick) School of Veterinary Studies EdinburghLesa Longley, MA BVM&S Cert ZooMed MRCVS for an exceptionally high level of achievement during her residency programme.
Mark Leddy, Vetoquinol's Marketing Department Manager said: "We are delighted to have been able to help these universities recognise and reward the achievements of staff and students over the past three years."
Animalcare has launched Buprecare into the UK and Ireland veterinary markets. Buprecare (POM-V) is a veterinary licensed analgesic, containing buprenorphine, for use in dogs and cats. It is licensed for post-operative analgesia in dogs and cats, and potentiation of the sedative effect of centrally acting agents in dogs.
This is the second major product the company has introduced in the last 18 months as Animalcare continues to grow its portfolio of veterinary products with the launch of an ACE inhibitor Benazecare (benazepril hydrochloride) earlier in 2007.
To complement the product launch, Animalcare is offering an ampoule breaker to help practice staff to open ampoules safely, together with a practice support package, containing pain scoring pads to aid in the assessment of pain of patients and judging of adequate analgesia requirements. In addition a dosing table and poster detailing common behavioural changes that can be associated with pain are available. Buprecare 0.3mg/ml is available in 1ml ampoules, in cartons of 5 ampoules.
Stephen Wildridge, Managing Director of Animalcare Ltd. said: "We have a very exciting time ahead with the launches of several new pharmaceutical products over the next twelve months, and the proposed expansion of our business into the major European veterinary markets."
Please contact your Animalcare representative, or ring 01904 487687 for more details.
Fort Dodge Animal Health has announced it is working with the authorities to put measures in place to make its West Nile Virus vaccine, licensed in the United States, available to the European equine market. These measures will ensure a vaccine is readily available in the event of an outbreak in the UK.
This news comes as the Zooprophylactic Institute of Teramo, the Italian National Reference Centre for Exotic Diseases, has confirmed an outbreak of WNV among horses in stables in the northern province of Ferrara. About 20 horses are believed to have been affected.
Fort Dodge was the first company to develop and fully license a vaccine to protect horses against this potentially deadly disease. An inactivated whole virus vaccine, it was the only vaccine available in the United States at the height of the 2002 outbreak, which affected 15,000 horses. The U.S. Department of Agriculture credited the vaccine with contributing to the 70 per cent decline in U.S. equine West Nile cases since the height of the outbreak. WNV is now considered endemic in all areas of North America.
"As this latest outbreak of WNV in Italy highlights, the disease presents an increasing threat to the equestrian sector in Europe," says Helen Barnes, EMEA Equine Business Manager for Fort Dodge. "With little current natural immunity among the equine population, the consequences of a major outbreak could be devastating."
"Until now, horse owners in Europe have perhaps believed WNV is not a disease they should be concerned with but the outbreak in Ferrara came out of the blue, and at a time when a human case of WNV was also reported in the same province. This situation of both human and equine cases being reported is identical to that seen in the outbreaks in the United States. It's a stark reminder of the challenge this disease poses, particularly as environmental factors, such as global warming and heavy rains threaten to create mass breeding grounds for mosquitoes," says Barnes.
"Our experience with WNV in the United States has given us an exceptional understanding of the disease and the importance of vaccination. We now look forward to working in partnership with the European governments, the EU Commission and the veterinary community across Europe to help build understanding and knowledge of this dangerous emerging disease threat."
ECM of France, a specialist in veterinary ultrasound solutions, has launched VIRTUAL SCAN - an ultrasound scanner for pig farmers and veterinarians. ECM says the scanner offers an alternative to screenless A-Mode Doppler devices, cheaper ultrasound devices, which are often poor quality.
VIRTUAL SCAN weighs 450 grams. It is equipped with an internal five-hour battery and a 5MHz sector probe. ECM says the instrument is extremely easy to handle - all the user needs to do is switch it on and the hand-held instrument is instantly ready to perform an ultrasound on sows.
VIRTUAL SCAN is a compact device (11cm x 18.5cm x 4.5cm) and does not require an external cable. According to the company, it can be used in any livestock facility, even inside narrow, hard-to-reach stalls. The screen is positioned in such a way that the image is always visible.
Using ECM's scanner, pregnancy tests can be performed as early as 21 days after insemination, so it is possible to re-inseminate any unfertilised sow without wasting a costly additional cycle. The image is easy to interpret. After use, the VIRTUAL SCAN ultrasound instrument is easy to clean with a damp cloth or water.
ECM, which is headquartered in Angoulême (in south-western France), develops and manufactures specialist veterinary-science devices. The company also provides training in ultrasound techniques, the correct way to move the probe and how to interpret the ultrasound image.
For more information, please contact:
Simon QuarmbyHOLMEFIELD Farm ServiceAgriculture HouseMurton LaneMurtonYorkT019 5UF
tel : (44) 1904 481.490fax : (44) 1904 481.211email : simon@hfsvets.com
Or visit: http://www.agroscan.com/ and http://www.ecmscan.com/
Intervet/Schering-Plough Animal Health, has launched a new guide entitled ‘Your guide to Exotic Diseases', to educate horse owners on these potentially fatal, insect-borne diseases, some of which are zoonotic.
Joining the company's guides on respiratory disease and vaccination, the leaflet features information on West Nile Virus, African Horse Sickness, Equine Infectious Anaemia (Swamp Fever) and Equine Encephalitis including overviews of each of the diseases and their clinical signs.
Spread by a variety of insect-borne vectors including midges, mosquitoes and horseflies, climate change is increasing the risk of exotic diseases having a severe impact on the country's equine industry. What's more, African Horse Sickness is transmitted from animal to animal by infected biting Culicoides midges, the same midges that carry the Bluetongue virus which has threatened UK livestock this year.
"It's essential that horse owners are aware of the threat of exotic diseases coming in from overseas and the clinical signs to look out for, especially during the summer and autumn months when diseases transmitted by insects are more likely to appear." comments Tim Zoch, Marketing Manager at Intervet/Schering-Plough Animal Health. "Our new leaflet features easy-to-understand overviews of each of the diseases to help educate owners, and practices can expect strong demand from their clients"
For further information about Intervet/Schering-Plough's range of horse owner guides, including ‘Your guide to Exotic Diseases', please contact your Intervet/Schering-Plough Account Manager or call the Veterinary Support Group on 01908 685685.
Some interesting statistics from insurers Petplan today. Turns out that almost a third of 3000 pet owners surveyed by the company admitted accidentally injuring their pet, resulting in an average vet bill of £170.
Nearly 6 out of 10 owners admitted stepping on their pet, while 21% confessed to dropping them. The next biggest threat posed to pets by their owners was accidental poisoning.
The survey found that dogs are most likely to be stepped on, whilst guinea pigs are most likely to be dropped by their overly affectionate owners.
The survey also found that 1/3rd of pets hurt themselves jumping off furniture, and one in five have been injured running in front of a car.
More than a third of pets injure themselves eating something they shouldn't, including the dog that swallowed a pair of knickers, which ended up costing £1,200 to retrieve.
From 31 October 2008, veterinary surgeons will again be allowed to charge animal owners for writing prescriptions, when a three-year ban on such fees comes to an end.
The Supply of Relevant Veterinary Medicinal Products Order 2005 was introduced by the former Department of Trade and Industry (DTI) to implement recommendations from a 2003 Competition Commission inquiry into the supply of prescription-only veterinary medicines, which, among other things, found that prescription charges were against the public interest. It was hoped by the DTI that the move would benefit consumers by providing for pharmacies and other suppliers to have an opportunity to establish themselves as competitors to veterinary surgeons in supplying prescription-only veterinary medicines.
Although veterinary practices will be able to make a charge for writing a prescription from 31 October 2008, one thing does not change: practices must not charge different fees for other services or veterinary medicines to those who take a prescription and those who do not.
Jill Nute, RCVS President said: "The OFT (Office of Fair Trading) will monitor the reintroduction of prescription charges and has indicated that the level of monitoring will be proportionate to the perceived need - how well the market is working.
In addition, the RCVS will monitor complaints that relate to prescription charges and meet with the OFT to review the situation in six months time. Care must be taken to ensure that prescription fees are calculated sensibly, or the zero-fee ruling may be reintroduced."
The OFT has advised that veterinary practices must not agree between themselves what constitutes a suitable fee: it is prohibited by competition law.
General guidance for members of the profession is available on RCVSonline (Advice Note 15): www.rcvs.org.uk/advicenotes. Guidance for members of the public is also available online at:
http://www.consumerdirect.gov.uk/before_you_buy/thinking_about/560042/
Other Competition Commission recommendations, such as displaying a price-list of the ten relevant veterinary medicinal products most commonly prescribed during a recent period, have been enforced since 2005 via the RCVS Guide to Professional Conduct and will remain in place.
VetSurgeon.org member Sam Westhead, a vet from Farnborough, has secured sponsorship from Vets Now and Vet Times in his entry to the grueling Ironman 70.3 World Championship challenge in Clearwater in Florida this November
The two organisations will each sponsor Sam £250 for taking part in the challenge.
Sam, who works at Grazely Vets in Farnborough, qualified for the World Championship event earlier this year in the Singapore Ironman 70.3, coming first in the veterans group and a not too shabby 30th overall!
Clearly not for the faint hearted, the Ironman 70.3 World Championship consists of a 1.2 mile swim, a 56-mile bike and a 13.1 mile run, adding up to 70.3 miles of total racing.
Speaking about his entry to the race, Sam commented; "The training is going well and I'm trying to focus on keeping up the momentum and enthusiasm for the race as the countdown is now on! I'm obviously looking forward enormously to arriving in Florida in a few weeks time and competing in the event - it's a real achievement to have got to this stage. I would like to say a big thank you to Vets Now and the Vet Times for their extremely kind donations which will go some way to covering the cost of my flights to and from the event."
Richard Dixon, Group Managing Director for Vets Now said; "Sam is an extremely dynamic individual who displays wonderful passion for both his career and in living life to the full. I know he has trained hard to qualify for the event and to get to this stage and Vets Now is delighted to be backing Sam in this particularly grueling and ambitious challenge. We wish him well in his final few weeks of training and of course in the event in November."
Free-range table-birds being reared from slower growing breeds need a different vaccination regime from that of faster-growing broilers, when being immunised against Gumboro disease.
This previously-unknown fact has emerged from laboratory and field trials, involving several hundred thousand birds on farms throughout the UK, carried out by Lohmann Animal Health in conjunction with poultry vets.
"When using a ‘hot' vaccine conventional broilers in the UK are normally vaccinated at around 14-16 days when their maternal immunity is waning," said Adam Goddard, Lohmann's UK sales consult. "However, we've found this maternal immunity lasts longer in the slow-growing breeds which are reared both indoors and out."
Realistically, the correct day of vaccination for free-range table-birds is more likely to be achieved by using the vaccine date predictions for broiler-breeders, rather than that of the broiler, under the Deventer formula, which gives calculations for different types of bird.
He therefore advises producers to consult their vets who can take blood samples to get an accurate prediction regarding optimum timing of vaccination with their own particular flocks.
"Our trials have shown that, in general, and depending upon the breed used, the decline in maternal immunity is delayed - perhaps for 4-5 days. So, in order to get a better ‘take', we recommend vaccinating these birds later or using an IBD vaccine that ‘takes' in the presence of high maternal immunity." said Mr Goddard.
Gumboro disease - also known as Infectious Bursal Disease - can cause severe losses in chickens and outdoor-reared birds are more susceptible to the disease due to environmental influences.
Earlier this year Lohmann Animal Health launched a new ‘hot' vaccine, classified as an ‘intermediate plus' against the very virulent form of Gumboro disease. The company says that because of its ability to break through high levels of maternal antibodies, it allows vaccination to take place earlier than with other existing vaccines.
The RCVS has accredited four more universities to assess modules for its Certificate in Advanced Veterinary Practice (CertAVP). This means that there are now 78 modules for candidates to choose from, with many modules available through more than one university, giving veterinary surgeons a real choice as to how they work towards postgraduate qualifications.
The RCVS CertAVP Subcommittee has approved applications from the Universities of Edinburgh, Glasgow, Liverpool and the West of England (in partnership with Hartpury College).
A very broad range of modules is now available, covering most species and many disciplines. They include some firsts for the CertAVP - equine modules will be available through both Edinburgh and Liverpool universities, and Edinburgh will also be assessing modules in equine dentistry, laboratory animal science and cattle and sheep medicine, amongst others. Glasgow's range includes modules in veterinary public health, as well as emergency critical care, while the University of the West of England's offering includes the key skills modules, and ‘B' modules in small animal, equine and production animal practice.
These universities now join the Royal Veterinary College and the Universities of Cambridge and Middlesex in being accredited to assess modules. While all of the accredited universities provide courses to support candidates working towards modules, including distance-learning options and online support, they must also offer an assessment-only route for those who prefer self-study, or who want to attend courses elsewhere.
The modular CertAVP was launched during 2007 and gives candidates the benefit of a mix and match style of learning. This aims to meet the needs of those who are committed to planned continuing professional development (CPD) but who need to balance this with busy practice life.
The new Certificate also better meets the needs of those whose practice interests change over the enrolment period, or who want to combine study across different species and disciplines to suit their practice caseload. Previously there was little flexibility built into the examination system.
"We are delighted that the list of modules available has nearly tripled this month," says Freda Andrews, RCVS Head of Education. "Interest in the new certificate is growing, and there are already around 200 people enrolled with RCVS for various modules. So it's great news that these universities are now backing the Certificate and enabling much greater choice for veterinary surgeons studying for the qualification."
Full details of the new modules are available on RCVSonline at www.rcvs.org.uk/modcerts
The European Society of Feline Medicine (ESFM) is expanding the scope and reach of its Journal of Feline Medicine and Surgery (JFMS) in January 2009 by moving to a monthly schedule and introducing six colourful new clinical issues which will alternate with the now well-established classic issues.
JFMS, the official journal of both ESFM and of the American Association of Feline Practitioners (AAFP), has an excellent citation index and is ever-growing with record numbers of high quality papers being received. The clinical issues of JFMS will be highly visual and contain commissioned clinical review articles enhanced by case work-ups, self-assessment questions and multimedia online elements to provide practitioners with the latest author guided evidence-based information as a tool for day-to-day feline treatment.
‘As a practitioner-orientated organisation we wanted to do more for the vet in practice. So, for ESFM's 10th anniversary we are again breaking the mould by introducing six new issues a year containing well illustrated clinical reviews, aimed specifically at practice, from the best authors around the world,' said Claire Bessant Chief Executive of the ESFM and its founding organisation the Feline Advisory Bureau (FAB).
‘The aim of JFMS ‘clinical' is to turn vision into reality by delivering opinionated reviews, and some ‘outside the box' thinking, from respected clinicians to the front line of veterinary practice,' says JFMS editor Dr Andy Sparkes.
From January, members of ESFM will receive a monthly journal - six classic (the current JFMS) and six JFMS clinical issues - classic and clinical - pure and applied - the best of feline veterinary science.
If you would like a mini-sample of the new journal then contact the FAB/ESFM office Margaret@fabcats.org or go to www.fabcats.org/esfm where you can download a pdf or view it on screen.
Individual membership of ESFM is £110 pa (Euros 145) for UK and overseas. Practice membership is £170 for the UK, £190 overseas (soruE 240). ESFM members are entitled to reduced rates to ESFM congress and gain online access to JFMS papers. Full details are available at www.fabcats.org/esfm.
The RCVS has announced that registrations for the new RCVS Register of Veterinary Practice Premises will be accepted from 1 November 2008, allowing all those who wish to supply medicines from veterinary practice premises from 1 April 2009 onwards a full five months to comply with the latest medicines legislation.
In order to fulfil its obligations under European law to maintain and improve traceability of, and accountability for, veterinary medicines, the UK Government decided that any veterinary surgeon may only supply veterinary medicinal products (VMPs) from premises registered with the Secretary of State, with effect from 1 April 2009.
The Veterinary Medicines Directorate (VMD) is responsible for the inspection and registration of practices under the Veterinary Medicines Regulations. Steve Dean, VMD's Chief Executive, says the new veterinary practice premises register will complete the UK information base by bringing veterinary practices in line with other suppliers of veterinary medicines who already have to operate from registered premises.
The Register will enable the supply of veterinary medicines by veterinary surgeons, including controlled drugs, to be subjected to inspection and verification. As a result, DEFRA Ministers and the European Commission can be re-assured that veterinary medicines are being supplied in the UK in accordance with EC legislation.
In discussion with the VMD, it was agreed that the most appropriate body to maintain this register would be the RCVS, not least because the College already manages the RCVS Practice Standards Scheme and publishes the (voluntary) Directory of Veterinary Practices, so has the necessary systems already in place. The register will be published on RCVSonline and updated quarterly.
Whilst there will now be a statutory fee levied for each practice premises registered on the new Register, the College's existing database framework has kept this to a relatively low £40 compared to what other bodies might have had to charge after starting from scratch.
Practices could appear in the Directory for free because the cost of producing it was partially covered by subsequent data sales. However, the new Register will need to be self-funding, as the data it contains will be freely available online.
Not all practices will have to pay the statutory fee. RCVS President Jill Nute said: "For those practice premises already accredited under the RCVS Practice Standards Scheme (PSS), the fee will be taken from their existing PSS annual fee.
"What's more, accredited practices will not face additional four-yearly inspections by VMD inspectors (unless there is an investigation for enforcement purposes) as their PSS inspections already ensure that they keep up to date with current medicines legislation."
Practice premises that have applied to join the Scheme, but have not yet been accredited, will not face additional VMD inspections either, but will still need to pay the statutory fee.
To help practices understand the new requirements and what they need to do before next April, the RCVS has produced a range of guidance, including a series of Frequently Asked Questions (www.rcvs.org.uk).
"In particular, we hope this guidance will help to explain which premises are likely to be considered ‘veterinary practice premises' and the difference between those premises and places where medicines might simply be stored or kept," said Mrs Nute.
"It is important to realise that there is a legal requirement to register veterinary practice premises for the supply of medicines, and a professional obligation, set out in the Guide to Professional Conduct, to keep a record of where all medicines are stored or kept. This record should avoid the need for additional registration of car boots, farms and homes."
Over the coming weeks, application forms will be posted to all practices currently listed in the Directory and accredited under the PSS, containing all the practice information currently held. These forms must be checked, signed and returned, even if no fee is due. Separate application forms will be available for any non-accredited practice premises not published in the Directory, and a letter will be sent to all RCVS members to ensure the whole profession is aware of the new requirements.
A campaign to reform English libel law to allow for robust criticism of scientific and medical claims without fear of legal action has been launched by journalist and author Simon Singh. It's a campaign which anyone working in the caring professions might wish to support.
The campaign comes as a consequence of legal action taken against Mr Singh by The British Chiropractic Association, which took exception (perhaps unsurprisingly) to an article he'd written in The Guardian. In the article, Mr Singh denounced claims on the BCA website that its members could use spinal manipulation to treat children with colic, ear infections, asthma, sleeping and feeding conditions, and prolongued crying as 'bogus', and criticised the BCA for 'happily promoting' these claims.
Out of curiosity, VetSurgeon rang the BCA press office this morning, and asked to be given the references for studies which it feels would support the original claims made on its site. Non have been forthcoming so far, which is a surprise. Under the circumstances, we'd have expected the BCA would have a raft of supporting evidence readily available.
But this isn't really about whether or not chiropractic works or not. The case seems to hinge upon whether Mr Singh's article implied that the BCA was being deliberately dishonest, or just delusional. He say's the latter. Unfortunately for him, Mr Justice Eady recently ruled the former, leaving Mr Singh with a bill for £100,000 worth of legal fees.
Mr Singh is to appeal. At stake is the freedom to be able to challenge scientific claims without fear of being sued. If you'd like to support this campaign, visit senseaboutscience.com and add your name to the 7000 others (including some pretty illustrious names) who have already done so.
CEVA Animal Health has announced that all dogs entering Dogs Trust's 17 Rehoming Centres will now be fitted with a D.A.P.® collar to help reduce their stress levels while in a kennel environment. This decision was taken following a highly successful trial1 at Dogs Trust's state-of-the-art Rehoming Centre in West London.
The trial revealed that dogs wearing D.A.P.® collars while in kennels were less likely to display canine stress indicators, such as barking and pacing around kennels, and were more likely to lie down and rest; signs that dogs are more relaxed.
Chris Laurence, veterinary director at Dogs Trust, said: "Dogs Trust trialled D.A.P.® collars on dogs being admitted at our Harefield Rehoming Centre. Many dogs are very stressed by their first experience in a kennel environment and it was shown that the use of a collar significantly reduced their stress levels.
"Centre staff were impressed with the positive changes in behaviour that were shown during the trial. Dogs were far more relaxed and less reactive to the inevitable stressful elements of their environment. We will now be using D.A.P.® collars on all dogs entering our Rehoming Centres in tandem with the other practices we already employ to reduce kennel stress.
"Stressed dogs are more difficult to rehome so we hope the use of DAP® to reduce stress levels will be beneficial to both their welfare and our rehoming."
For further information on D.A.P.®, please contact your local CEVA Animal Health territory manager, or visit www.ceva.uk.com.
The Blue Cross is calling for nominations from veterinary practices across the country for its Veterinary Nurse of the Year Award 2009.
The annual award is presented at the British Veterinary Nursing Association (BVNA) Annual Congress. It recognises the contribution of veterinary nurses in educating the public about responsible pet ownership and the welfare of pets in the community. This year's Congress will take place on 9-11 October at the Kettering Conference Centre, Northamptonshire.
Last year's award was won by Rebecca Darbyshire for her outstanding contribution to animal welfare, both within her veterinary practice and among the local community in Pocklington, York.
Rebecca Darbyshire was nominated by vet and colleague Matt Brash at Battlefields veterinary clinic in Pocklington.
Mr Brash said: "Rebecca is an outstanding, unassuming professional nurse. She runs all of the clinics that a modern day nurse does, but still has the time for anybody - whatever they need, whenever they need it. She has developed such a close relationship with our clients that they would often rather see her than a vet!"
Nominations for this year's award can be made by completing the nomination form on The Blue Cross website at: www.bluecross.org.uk/BVNA2009 or by contacting Sally Leathem on 01993 825577. The deadline for nominations is Friday 14 August 2009.
The Blue Cross has taken the lead in animal care for over a hundred years. Its four animal hospitals provide a lifeline for pet owners on low incomes. Its community vet services also cater for elderly and disabled people. Without the charity's hospitals, and the services they provide, many people would be without the benefits that pet ownership can bring.
A European study undertaken in horses to evaluate the efficacy of the key anthelmintic molecules fenbendazole, pyrantel, ivermectin and moxidectin in treating equine cyathostomins, has confirmed that resistance is developing against all the molecules with the exception of moxidectin.
Resistance to fenbendazole was highlighted as a particular issue with 80% of the yards tested in the UK and Germany showing resistance. Resistance to pyrantel also proved to be increasingly prevalent while cases of ivermectin resistance were emerging.
The Fort Dodge-sponsored study, the largest of its kind so far undertaken, took place during 2008 and was led by scientific teams from veterinary faculties in Italy and Germany. It was based on Faecal Egg Count Reduction Tests (FECRTs) of 1,704 horses at 102 yards in Italy, Germany and the UK. The calculation of FECR data was performed employing bootstrap analysis of group arithmetic means.
The study concluded that:
According to Dr Donato Traversa from the University of Teramo, Italy, who headed up the field work, the results confirm that single and even multiple drug resistance in equine cyathostomins is an increasing challenge in all three countries with resistance to fenbendazole and pyrantel a particular concern.
He said: "Our research highlights the necessity for vets, owners and managers to use those anthelmintic molecules that remain most effective in a manner which preserves their efficacy for as long as possible."
Professor Georg von Samson Himmelstjerna from Hannover University of Veterinary Medicine, which participated in the research, added: "Given the strong impact that resistant cyathostomins are likely to have on horse welfare, future parasite control plans should be based on integrated measures, involving both the correct use of anthelmintics, such as administering the correct dosing according to the animals weight, and only using products in the species for which it is licensed, as well as other approaches such as adequate pasture hygiene, low stocking rates and mixed grazing with other animals.
"We call on all concerned with equine health and welfare to take an active role in planning and monitoring effective worm control programs."
Pfizer has sponsored the publication of a new English-Polish dairy health guide for vets to give farmers.
The guide has been published to help farm staff from Poland improves their knowledge, skills and performance at work. Topics covered including milking routines, causes and control of clinical mastitis, intramammary tube infusion and dry cow therapy.
Copies are available free of charge from Pfizer Animal Health's Dairy Territory Managers, or by calling 01737 330727.
A survey of more than 3,000 farms has found that 16% employed foreign workers, among whom more than half were from Poland.1 According to Pfizer's livestock business director Tomas Rosival, Polish workers are keen on training and eager to put it into practice and get results.
He said: "Communication is the key. By presenting each topic in English and Polish on facing pages, the booklet helps develop workplace vocabulary and language skills as well as improving technical knowledge."
[1] Farm Business, 2009. The significance of migrant labour in UK agricultural employment. Survey of 3,375 farms.
Pet Blood Bank UK (PBBuk) launched its new mobile blood collection unit, donated by Royal Canin, at the University of Nottingham's School of Veterinary Medicine and Science on Wednesday, simultaneously collecting enough blood to save the lives of up to 32 dogs.
The blood collection session offered third-year university students an opportunity to learn about transfusion medicine and to practice their clinical skills on real life subjects, as they performed the pre-donation checks and tests under the supervision of Pet Blood Bank UK veterinary advisers.
Vanessa Ashall, Pet Blood Bank UK welfare officer and veterinary surgeon, said: "It is great for students to be able to see these animals. Transfusion medicine is a new science and I certainly wasn't taught about it as a veterinary student. Collaboration with veterinary schools is such a positive step, as we are able to educate the vets of the future on the benefits of transfusion medicine and blood typing, whilst giving them some real hands-on experience."
Veterinary support manager for Royal Canin, Chris Geddes, said: "We are really pleased to be able to assist Pet Blood Bank UK become more mobile and reach more donors. The charity's work is so important to the emergency and critical care of patients, as shown by the tremendous gratitude of the owners of blood recipients."
Golden retriever Beau was one such recipient who had received a transfusion last month after suffering a haemorrhage after surgery for gastric dilatation and volvulus. His owners, Janet and David Liggins, attended the event with a fully-recovered Beau and their other golden retriever, Lotti who gave blood.
Mrs Liggins said: "We can't speak highly enough of all the vets and vet nurses that cared for him - they did a tremendous job looking after Beau, and us! The Pet Blood Bank provided the blood that saved Beau's life. We are really pleased that Lotti was able to give blood. She was a star - the perfect donor!"
Veterinary practices wanting to encourage their clients to put dogs forward as donors, or which would like to support the work of Pet Blood Bank UK, should visit http://www.petbloodbankuk.org/ or contact Pet Blood Bank UK on 01509 232 222 or 0844 800 9925 (5p/min). Blood donors are needed for a second blood collection session at the Nottingham School of Veterinary Medicine and Science, Sutton Bonington campus, on Saturday, May 23: 10-4pm.
Fort Dodge has announced that a challenge study has demonstrated the ability of Duvaxyn® IE-T Plus equine influenza vaccine to cross protect against A/equi-2/Sydney/07 (H3N8) two weeks after a two dose primary course. This strain was responsible for the financially devastating equine influenza outbreak in Australia in August 2007.
Duvaxyn IE-T Plus is an inactivated whole virus equine influenza vaccine, adjuvanted with an aqueous-based adjuvant. According to Fort Dodge, experts at a recent WHO meeting on human vaccines expressed the view that whole virus vaccines have the potential to induce a stronger and more broadly based response to circulating influenza strains than those contained in sub-unit vaccines because of the presence of the full set of virus proteins in the vaccine*.
The study, conducted by the Animal Health Trust, involved two groups of EIV seronegative horses. The first group, consisting of seven vaccinates, were given two dose of Duvaxyn IE-T Plus, 28 days apart, and challenged with A/equi-2/Sydney/07 (H3N8) virus strain 14 days after the second vaccination. The second group of unvaccinated horses was challenged at the same time. Duvaxyn IE-T Plus caused a statistically significant reduction in both clinical signs of the disease and in viral shedding.
Helen Barnes, EMEA Equine Business Manager for Fort Dodge, said: "The results of this challenge study provide reassurance for owners that horses vaccinated with Duvaxyn will be protected against circulating strains of equine influenza, including the Sydney strain which proved so damaging.
"As the benefits offered by whole virus technology are increasingly recognised, the popularity of vaccines based on this technology is re-emerging, particularly to combat a potential pandemic.
"The entire Duvaxyn range of equine vaccines, including the recently licensed Duvaxyn WNV for West Nile Virus, are based on the whole virus approach as we believe it offers a broad and consistent level of protection."
Fort Dodge has released figures today which point to a continued modest slowdown in the UK veterinary sector, being mitigated by a slight increase in average transaction value (the amount a client spends in a year).
Matthew Rowe, Companion Animal Marketing Manager at Fort Dodge, said: "It's been clear for some time that the veterinary sector is being hit by static growth and an increasingly competitive environment. The reduction in turnover being experienced by many practices is primarily down to current clients visiting less often and fewer new clients being attracted."
Key findings of the Fort Dodge Index for the first quarter of 2009 are:
Alan Robinson said: "In the current climate, the only contributor to turnover growth in many practices seems to be a steady rise in the price of professional fees, consultations and surgery. These have continued to push up average transaction values (by 1.4%) and client values (1.2%) in this first quarter of 2009 despite reducing visit frequency. Drug related income increases seem to be driven by a small increase of POM mark-ups in many practices.
"But this alone will not sustain a successful business and, with transaction volumes still falling, the priority for practices is to maintain client footfall despite increasing competition and falling pet ownership. In today's market, retaining clients is a cheaper and more effective way to maintain client and patient numbers so an emphasis on 'bonding' clients though preventative health care and heath maintenance programmes is key.
"We're seeing a steady increase in the number of practices running these programmes but the percentage of pets involved is still woefully low so the message is that practices can and must do better.
Environmental household flea spray, Acclaim®, is now licensed to kill house dust mites. A common cause of allergies, house dust mites are present all year around, aggravating conditions such as atopic dermatitis.
Containing S-methoprene and permethrin, Acclaim is a fast-acting, odourless household spray which kills fleas and flea larvae and has 12 months' activity against flea egg development. It also kills ants, cockroaches, ticks and spiders and does not break down in sunlight in the home.
For information on CEVA Animal Health's complete range of household flea treatments, which includes the traditional pesticide sprays Acclaim® and Staykil® and the innovative non-pesticide product Skoosh®, please contact your local CEVA account manager.